| Study Details | To investigate the efficacy and safety of LNP023 compared with rituximab in the treatment of subjects with idiopathic membranous nephropathy |
| Protocol Number | CLNP023D12201 |
| Phase | II |
| Therapeutic Area | Nephrology |
| Subject Types | With Medical Condition |
| Indication | Idiopathic membranous nephropathy |
| Principal Investigator | A/Prof Jimmy Teo Boon Wee |
| Investigator Product / Device | LNP023 |
| Sponsor | Novartis Singapore Pte Ltd |
